- Home
- About
- Find staff
- Anna Linder
Anna Linder
Researcher
Department of Obstetrics and Gynecology-
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian
carcinoma
Anna Linder, S. Westbom-Fremer, C. Mateoiu, Amanda Olsson Widjaja, Tobias Österlund, S. Veerla, Anders Ståhlberg, B. Ulfenborg, Karin Sundfeldt
HUMAN REPRODUCTION - 2024 -
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium
study
E. Y. Kang, A. Weir, N. S. Meagher, K. Farrington, G. S. Nelson, P. Ghatage, C. H. Lee, M. J. Riggan, A. Bolithon, G. Popovic, B. Leung, K. Tang, N. Lambie, J. Millstein, J. Alsop, M. S. Anglesio, B. Ataseven, E. Barlow, M. W. Beckmann, J. Berger, C. Bisinotto, H. Bosmuller, J. Boros, A. H. Brand, A. Brooks-Wilson, S. Y. Brucker, M. E. Carney, Y. Casablanca, A. Cazorla-Jimenez, P. A. Cohen, T. P. Conrads, L. S. Cook, P. Coulson, M. Courtney-Brooks, D. W. Cramer, P. Crowe, J. M. Cunningham, C. Cybulski, K. M. Darcy, M. A. El-Bahrawy, E. Elishaev, R. Erber, R. Farrell, S. Fereday, A. Fischer, M. J. Garcia, S. A. Gayther, A. Gentry-Maharaj, C. B. Gilks, M. Grube, P. R. Harnett, S. P. Harrington, P. Harter, A. Hartmann, J. L. Hecht, S. Heikaus, A. Hein, F. Heitz, J. Hendley, B. Y. Hernandez, S. H. Polo, S. Heublein, A. Hirasawa, E. Hogdall, C. K. Hogdall, H. M. Horlings, D. G. Huntsman, T. Huzarski, A. Jewell, M. Jimenez-Linan, M. E. Jones, S. H. Kaufmann, C. J. Kennedy, D. Khabele, F. K. F. Kommoss, Rfpm Kruitwagen, D. Lambrechts, N. D. Le, M. Lener, J. Lester, Y. Leung, Anna Linder, L. Loverix, J. Lubinski, R. Madan, G. L. Maxwell, F. Modugno, S. L. Neuhausen, A. Olawaiye, S. Olbrecht, S. Orsulic, J. Palacios, C. L. Pearce, M. C. Pike, C. M. Quinn, G. R. Mohan, C. Rodriguez-Antona, M. Ruebner, A. Ryan, S. G. Salfinger, N. Sasamoto, J. M. Schildkraut, M. J. Schoemaker, M. Shah, R. Sharma, Y. B. Shvetsov, N. Singh, G. S. Sonke, L. Steele, C. J. R. Stewart, Karin Sundfeldt, A. J. Swerdlow, A. Talhouk, A. Tan, S. E. Taylor, K. L. Terry, A. Toloczko, N. Traficante, K. K. Van de Vijver, M. A. van der Aa, T. Van Gorp, E. Van Nieuwenhuysen, L. Van-Wagensveld, I. Vergote, R. A. Vierkant, C. Wang, L. R. Wilkens, S. J. Winham, A. H. Wu, J. Benitez, A. Berchuck, F. J. C. Dos Reis, A. DeFazio, P. A. Fasching, E. L. Goode, M. T. Goodman, J. Gronwald, B. Y. Karlan, S. Kommoss, U. Menon, H. P. Sinn, A. Staebler, J. D. Brenton, D. D. Bowtell, P. D. P. Pharoah, S. J. Ramus, M. Kobel
Cancer - 2023 -
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian
carcinomas
Karolin Heinze, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel C.Y. Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans Walter Vollert, Florian Heitz, Andreas du Bois, Philipp Harter, Marcel Grube, Bernhard Kraemer, Annette Staebler, Felix K.F. Kommoss, Sabine Heublein, Hans Peter Sinn, Naveena Singh, Angela Laslavic, Esther Elishaev, Alex Olawaiye, Kirsten Moysich, Francesmary Modugno, Raghwa Sharma, Alison H. Brand, Paul R. Harnett, Anna DeFazio, Renée T. Fortner, Jan Lubinski, Marcin Lener, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Helena Gronwald, Jacek Gronwald, Penny Coulson, Mona A. El-Bahrawy, Michael E. Jones, Minouk J. Schoemaker, Anthony J. Swerdlow, Kylie L. Gorringe, Ian Campbell, Linda Cook, Simon A. Gayther, Michael E. Carney, Yurii B. Shvetsov, Brenda Y. Hernandez, Lynne R. Wilkens, Marc T. Goodman, Constantina Mateoiu, Anna Linder, Karin Sundfeldt, Linda E. Kelemen, Aleksandra Gentry-Maharaj, Martin Widschwendter, Usha Menon, Kelly L. Bolton, Jennifer Alsop, Mitul Shah, Mercedes Jimenez-Linan, Paul D.P. Pharoah, James D. Brenton, Kara L. Cushing-Haugen, Holly R. Harris, Jennifer A. Doherty, Blake Gilks, Prafull Ghatage, David G. Huntsman, Gregg S. Nelson, Anna V. Tinker, Cheng Han Lee, Ellen L. Goode, Brad H. Nelson, Susan J. Ramus, Stefan Kommoss, Aline Talhouk, Martin Köbel, Michael S. Anglesio
Journal of Pathology - 2022 -
Single-molecule array assay reveals the prognostic impact of plasma LRIG1 in ovarian
carcinoma
A. L. L. de Melo, Anna Linder, Karin Sundfeldt, D. Lindquist, H. Hedman
Acta Oncologica - 2022 -
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse
Outcomes
N. S. Meagher, K. L. Gorringe, M. Wakefield, A. Bolithon, C. N. I. Pang, D. S. Chiu, M. S. Anglesio, K. A. Mallitt, J. A. Doherty, H. R. Harris, J. M. Schildkraut, A. Berchuck, K. L. Cushing-Haugen, K. Chezar, A. Chou, A. Tan, J. Alsop, E. Barlow, M. W. Beckmann, J. Boros, D. D. L. Bowtell, A. H. Brand, J. D. Brenton, I. Campbell, D. Cheasley, J. Cohen, C. Cybulski, E. Elishaev, R. Erber, R. Farrell, A. Fischer, Z. X. Fu, B. Gilks, A. J. Gill, C. Gourley, M. Grube, P. R. Harnett, A. Hartmann, A. Hettiaratchi, C. K. Hogdall, T. Huzarski, A. Jakubowska, M. Jimenez-Linan, C. J. Kennedy, B. G. Kim, J. W. Kim, J. H. Kim, K. Klett, J. M. Koziak, T. Lai, A. Laslavic, J. Lester, Y. Leung, N. Li, W. Liauw, B. W. X. Lim, Anna Linder, J. Lubinski, S. Mahale, C. Mateoiu, S. McInerny, J. Menkiszak, P. Minoo, S. Mittelstadt, D. Morris, S. Orsulic, S. Y. Park, C. L. Pearce, J. V. Pearson, M. C. Pike, C. M. Quinn, G. R. Mohan, J. Y. Rao, M. J. Riggan, M. Ruebner, S. Salfinger, C. L. Scott, M. Shah, H. Steed, C. J. R. Stewart, D. Subramanian, S. Sung, K. Tang, P. Timpson, R. L. Ward, R. Wiedenhoefer, H. Thorne, P. A. Cohen, P. Crowe, P. A. Fasching, J. Gronwald, N. J. Hawkins, E. Hogdall, D. G. Huntsman, P. A. James, B. Y. Karlan, L. E. Kelemen, S. Kommoss, G. E. Konecny, F. Modugno, S. K. Park, A. Staebler, Karin Sundfeldt, A. H. Wu, A. Talhouk, P. D. P. Pharoah, L. Anderson, A. DeFazio, M. Kobel, M. L. Friedlander, S. J. Ramus
Clinical Cancer Research - 2022 -
Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in
vivo
Malin Hagberg Thulin, J. Maatta, Anna Linder, S. Sterbova, Claes Ohlsson, Jan-Erik Damber, A. Widmark, E. Persson
Prostate - 2021 -
Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian
Tumors
Angela Barone, Anna Linder, Constantina Mateoiu, R. K. Larsen, O. Blixt, Susann Teneberg, Karin Sundfeldt
Frontiers in Oncology - 2020 -
RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate
cancer
Anna Linder, Karin Larsson, Karin Welén, Jan-Erik Damber
Prostate - 2020 -
Evaluation of regulator of G-protein signaling 2 (RGS2) at different stages of prostate cancer - Significance and clinical
potential
Anna Linder
2019 -
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer
progression
Anna Linder, M. Hagberg Thulin, Jan-Erik Damber, Karin Welén
Scientific Reports - 2018 -
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate
Cancer.
Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm, Aseem Anand, Anders Bjartell, Jan-Erik Damber, Karin Welén
The Prostate - 2017 -
Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this
region
Carola Oldfors Hedberg, Diego Garcia Dios, Anna Linder, Kittichate Visuttijai, Emma Samuelson, S. Karlsson, Staffan Nilsson, A. Behboudi
BMC Genetics - 2015